CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on November 19, 2020
WestPark Capital, Inc.
1900 Avenue of the Stars, Suite 310
Los Angeles, CA90067
As representative of the several underwriters
VIA EDGAR
November 19, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Lixte Biotechnology Holdings, Inc. (the “Company”) | |
| Registration Statement on Form S-1 | ||
| Filed on September 3, 2020 | ||
| CIK No. 0001335105 |
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on November 17, 2020, in which we requested the acceleration of the effectiveness of the above-captioned Registration Statement to 4:00 p.m., New York City time on November 19, 2020. We hereby formally withdraw our prior request for acceleration of the effective date of the above-captioned Registration Statement and hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:00 p.m., Eastern Time, on November 23, 2020, or as soon thereafter as is practicable.
[Remainder of Page Intentionally Left Blank]
| -1- |
Very truly yours,
WestPark Capital, Inc.
| By: | /s/ Richard Rappaport | |
| Richard Rappaport, Authorized Representative | ||
| Acting on behalf of themselves and as the Representative of the several Underwriters | ||
| -2- |